While NICE’s decisions have angered some doctors and patient groups -particularly some oncologists (肿瘤科医生) who say they are unable to prescribe expensive, life- extending cancer drugs- mainstream politicians, the media and most Britons accept NICE’s rare rejections as a necessary compromise to keep universal coverage affordable in the face of rising health -care costs. As NICE chairman Sir Michael Rawlins recently told TIME, "All health -care systems have implicitly, if not explicitly, adopted some form of cost control. In the U. S. , you do it by not providing health care to some people. That’s a rather brutal way of doing it. " NICE’s decisions hear the loudest voice of disapproval from